BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2190386)

  • 1. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
    Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
    Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 6. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of cyclosporine monitoring in renal transplantation.
    Lindholm A
    Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
    Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
    Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
    Oesterwitz H; Strobelt V; May G; Horlbeck R
    Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1193-6. PubMed ID: 2349681
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic activity of cyclosporine metabolites.
    Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
    Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 16. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of a low-dose two-drug regimen of oral cyclosporine and delayed alternate day prednisone for immunosuppression in cadaver kidney transplantation.
    Belitsky P; MacDonald A; Cohen A; VGivner M; Sketris I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):78-81. PubMed ID: 3291314
    [No Abstract]   [Full Text] [Related]  

  • 19. Summary on therapeutic drug monitoring for renal transplantation.
    Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.